SitemapKlarity storyJoin usMedicationServiceAbout us
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
based on 0 reviews
fsaAccept major insurances and cash-pay
fsaHSA & FSA accepted; best-value for top quality care
fsaSame-day mental health, weight loss, and primary care appointments available
Excellent
unstarunstarunstarunstarunstar
staredstaredstaredstaredstared
based on 0 reviews
fsaAccept major insurances and cash-pay
Back

Blog Archives

Published: Jul 15, 2026

Share

Does Cigna Cover Weight Loss Treatment in West Virginia? A 2026 Guide

Share

Written by Klarity Editorial Team

Published: Jul 15, 2026

Does Cigna Cover Weight Loss Treatment in West Virginia? A 2026 Guide
Table of contents
Share

Last updated: July 15, 2026




2026 Key Update — Cigna/ESI Zepbound Status: Unlike some competitors, Cigna’s pharmacy benefit manager, Express Scripts (ESI), did not remove Zepbound (tirzepatide) from its commercial formulary. Zepbound remains available at Tier 3–4 with prior authorization for eligible Cigna members — an important distinction for West Virginia residents comparing weight loss coverage options. See if Klarity’s licensed WV providers may be able to help you start treatment →

If you have Cigna health insurance in West Virginia and are exploring weight loss treatment options, understanding what your plan may cover — and what steps are required — can make the difference between starting treatment and facing unexpected out-of-pocket costs. This guide covers Cigna’s 2026 weight loss formulary through Express Scripts (ESI), prior authorization requirements under West Virginia Senate Bill 267, the Electronic Prescribing for Controlled Substances (EPCS) rules that apply to certain weight loss medications, and how to verify your specific benefits before booking an appointment.

Cigna Health Plans Available in West Virginia

Cigna offers several commercial plan types in West Virginia for 2026. The type of plan you have affects your network access, referral requirements, and cost-sharing structure:

  • Open Access Plus (OAP): The most common employer-sponsored Cigna plan in WV. No referral required to see a specialist, including weight loss medicine providers. Access to the national Cigna network.
  • LocalPlus / SureFit: A network-restricted plan with lower premiums. Verify that your weight loss provider is in the LocalPlus network before scheduling — out-of-network care typically carries significantly higher cost-sharing or no coverage.
  • HMO: Requires a primary care physician (PCP) referral before seeing a weight loss specialist. Check your plan documents to confirm referral requirements.
  • ACA Marketplace Plans: Cigna’s West Virginia Marketplace plans (on-exchange and off-exchange) follow ACA essential health benefits (EHB) rules. Coverage for weight loss medications varies by plan tier and may require prior authorization.

Note: Cigna also administers many self-funded employer plans in West Virginia. Self-funded plans may have different formulary structures, prior authorization rules, and cost-sharing than the standard commercial plans listed above. Always verify benefits through your member portal at myCigna.com or by calling Cigna member services at 1-800-244-6224.

Cigna Weight Loss Drug Coverage: ESI Formulary 2026

Cigna administers its pharmacy benefits through Express Scripts (ESI). The following table reflects the typical ESI commercial formulary tier placement and prior authorization requirements for common weight loss medications in 2026. Actual coverage depends on your specific plan design — verify with your plan documents or Cigna member services.

MedicationDrug ClassESI Tier (Typical)Prior AuthorizationNotes
Wegovy (semaglutide)GLP-1 agonistTier 3–4Yes — BMI + comorbidity criteriaNon-scheduled; EPCS inapplicable
Zepbound (tirzepatide)GLP-1/GIP dual agonistTier 3–4Yes — BMI + comorbidity criteriaNOT removed from ESI formulary — key differentiator vs. CVS/Caremark
Saxenda (liraglutide)GLP-1 agonistTier 3–4Yes — PA requiredNon-scheduled; EPCS inapplicable
Contrave (naltrexone/bupropion)Opioid antagonist/NDRITier 2–3PA likely — verify with planNon-scheduled; EPCS inapplicable
Qsymia (phentermine/topiramate ER)Stimulant combinationTier 2–3Yes — PA + REMS enrollmentSchedule IV; EPCS applies in WV under § 60A-4-403a; REMS certification required
Phentermine (generic)Sympathomimetic stimulantTier 1–2Typically no PA — quantity limits applySchedule IV; EPCS applies in WV under § 60A-4-403a; short-term use only
Orlistat (generic)Lipase inhibitorTier 1–2Typically no PANon-scheduled; EPCS inapplicable
Alli (orlistat OTC)Lipase inhibitor (OTC)Not coveredN/AOTC drugs generally not covered under prescription benefit
Mounjaro (tirzepatide)GLP-1/GIP dual agonistTier 3–4Yes — for T2D indication onlyFDA-approved for Type 2 diabetes, not weight loss; covered for diabetes indication
Ozempic / Rybelsus (semaglutide)GLP-1 agonistTier 3–4Yes — for T2D indication onlyFDA-approved for Type 2 diabetes; Ozempic off-label weight loss typically not covered

Disclaimer: Formulary placement, tier assignments, and PA requirements may vary by plan type, employer group, and plan year. Always verify your specific benefits at myCigna.com or by calling 1-800-244-6224 before filling a prescription.

Cigna vs. CVS/Caremark: The Zepbound Difference

One of the most clinically significant formulary developments of 2025–2026 was CVS/Caremark’s decision to remove Zepbound from its commercial formularies — a decision that affected members on Aetna and other CVS/Caremark-administered plans. CVS/Caremark subsequently reinstated Zepbound effective October 1, 2026, following significant member and provider advocacy.

Cigna/ESI did not remove Zepbound. Throughout this period, Zepbound remained on the ESI commercial formulary at Tier 3–4 with standard prior authorization requirements. For West Virginia Cigna members considering tirzepatide for weight loss, this means that coverage continuity was maintained — no formulary gap or forced transition to an alternative medication occurred.

This distinction is worth noting when comparing plans or when speaking with a provider about GLP-1 coverage options. If your employer offers a choice between Cigna/ESI and an Aetna/CVS Caremark plan, the formulary stability of Zepbound on ESI may be a relevant factor in your benefits decision.

Electronic Prescribing for Controlled Substances (EPCS) in West Virginia

West Virginia’s controlled substance prescribing law, W. Va. Code § 60A-4-403a, requires electronic prescribing for all controlled substances — not just Schedule II as in most states. This is a WV-specific nuance that affects which weight loss medications require an electronic prescription.

For weight loss medications specifically:

  • GLP-1 agonists (Wegovy, Zepbound, Saxenda) — EPCS does not apply. These medications are not controlled substances under federal or West Virginia law. They can be prescribed through standard electronic or written prescription channels.
  • Contrave (naltrexone/bupropion) — EPCS does not apply. Contrave is not a controlled substance. Standard prescribing applies.
  • Orlistat — EPCS does not apply. Orlistat is not a controlled substance.
  • Phentermine (Schedule IV) — EPCS applies under § 60A-4-403a. Phentermine is a Schedule IV controlled substance. West Virginia’s all-controlled-substances EPCS mandate requires electronic prescribing. Prescribers must be EPCS-compliant to prescribe phentermine in WV.
  • Qsymia (phentermine/topiramate ER, Schedule IV) — EPCS applies under § 60A-4-403a, and REMS enrollment is also required. Qsymia carries both the Schedule IV EPCS requirement and an FDA Risk Evaluation and Mitigation Strategy (REMS) mandate requiring prescriber and pharmacy certification. Patients do not manage EPCS compliance directly — it is handled at the prescriber level.

For most Cigna WV members pursuing weight loss treatment, the EPCS requirement is effectively handled by the prescriber. However, verifying that your provider is EPCS-compliant (and REMS-certified if prescribing Qsymia) is a practical step that can prevent prescription delays.

Prior Authorization Requirements: West Virginia Senate Bill 267

West Virginia Senate Bill 267 (2024) established electronic-only prior authorization submission requirements for commercial insurers operating in West Virginia. Under SB 267:

  • All Cigna WV prior authorization requests must be submitted electronically via Availity. Paper PA forms are no longer accepted for commercial Cigna plans in West Virginia.
  • Providers submit PA requests through the Availity portal at availity.com.
  • Members can track PA status through myCigna.com or by calling Cigna member services.

Typical prior authorization criteria for weight loss medications on Cigna/ESI commercial plans in 2026 may include:

  • BMI ≥ 30 kg/m², or BMI ≥ 27 kg/m² with at least one weight-related comorbidity (type 2 diabetes, hypertension, hyperlipidemia, obstructive sleep apnea, or cardiovascular disease)
  • Documentation of a structured weight management program or lifestyle intervention attempt
  • Absence of contraindications (e.g., personal or family history of medullary thyroid carcinoma for GLP-1 agonists)
  • Prescribing by a licensed provider with appropriate prescribing authority for the specific medication

PA timelines under Cigna commercial plans typically follow these windows:

  • Standard PA: 2–3 business days from submission
  • Urgent/expedited PA: 24–72 hours when clinical urgency is documented
  • First-level appeal: 30–60 days from denial date (review your denial letter for the applicable deadline)

Does West Virginia’s Mental Health Parity Law Apply to Weight Loss?

W. Va. Code § 33-25-8r et seq. is West Virginia’s mental health and substance use disorder parity statute. This law requires commercial insurers to apply the same coverage limitations to mental health and SUD benefits as they apply to comparable medical/surgical benefits.

This statute does not govern weight loss treatment coverage. Weight loss is not classified as a mental health or substance use disorder condition under MHPAEA or the WV parity statute. The coverage frameworks that govern weight loss medication coverage for Cigna WV members are:

  • ACA Essential Health Benefits (EHB): ACA Marketplace plans must cover EHBs, which include preventive services. However, FDA-approved weight loss medications are not universally required EHBs — coverage depends on plan design and state benchmark plan requirements.
  • ERISA (Employee Retirement Income Security Act): Self-funded employer plans are governed by ERISA and are not required to follow West Virginia’s state insurance mandates, including WV weight loss coverage requirements.
  • Employer plan design: For most employer-sponsored Cigna plans, weight loss medication coverage is a plan design choice. Some employer plans include robust GLP-1 coverage; others exclude it or require stepped criteria.

If you believe your Cigna plan is wrongly denying weight loss medication coverage, you may have appeal rights under ERISA or through the WV Insurance Commissioner. Contact information is listed below.

Note on Medicare GLP-1 Bridge Program

Effective July 1, 2026, CMS launched a Medicare GLP-1 Bridge program providing eligible Medicare Advantage members access to Wegovy, Zepbound, and Foundayo at $50/month. This program applies to Medicare Advantage plans only — it does not apply to Cigna commercial plans, self-funded employer plans, or ACA Marketplace plans. If you have Cigna commercial coverage (through an employer or the Marketplace), the Medicare GLP-1 Bridge program is not relevant to your benefits.

How to Verify Your Cigna WV Weight Loss Coverage

Before scheduling a weight loss consultation, the following five-step verification process may help you understand your specific benefits and avoid unexpected costs:

  1. Log in to myCigna.com and navigate to “Benefits” → “Prescription Drug Benefits.” Search for your specific medication (e.g., “tirzepatide” or “semaglutide”) to see your plan’s formulary placement and cost-sharing.
  2. Confirm your plan type: OAP, LocalPlus/SureFit, HMO, or Marketplace. If you have a LocalPlus or HMO plan, verify that your provider is in-network before booking.
  3. Check for prior authorization requirements: If your medication requires PA, ask your provider to submit a PA request through Availity before your appointment. Having the PA in progress before your consultation may reduce delays.
  4. Verify EPCS and REMS compliance for phentermine/Qsymia: If your provider plans to prescribe phentermine or Qsymia, confirm they are EPCS-compliant in West Virginia and (for Qsymia) REMS-certified.
  5. Review your Explanation of Benefits (EOB): After any prescription is filled, review your EOB through myCigna.com to confirm the claim was processed correctly under your plan’s weight loss benefit.

Klarity’s licensed WV providers may be able to help you navigate weight loss treatment options — verify your benefits today →

Klarity Health: Weight Loss Treatment with WV-Licensed Providers

Klarity Health connects West Virginia residents with a network of 2,000+ licensed providers who offer telehealth weight loss consultations. Klarity providers are familiar with Cigna’s PA requirements, EPCS compliance mandates under West Virginia law, and the practical steps for getting weight loss medications covered.

When you book through Klarity, your provider can:

  • Evaluate your eligibility for FDA-approved weight loss medications including Wegovy and Zepbound
  • Submit prior authorization requests through Availity on your behalf, per WV SB 267 requirements
  • Prescribe electronically (EPCS-compliant) for Schedule IV medications including phentermine and Qsymia where appropriate
  • Help you understand your Cigna/ESI formulary options and cost-sharing before starting treatment

Coverage for weight loss treatment varies by Cigna plan. Klarity recommends verifying your specific benefits before your first appointment. Learn more about weight loss treatment options at Klarity →

Contact Information

  • Cigna Member Services: 1-800-244-6224 (available on the back of your Cigna ID card)
  • Express Scripts (ESI) Pharmacy Help Desk: 1-800-835-3784
  • myCigna.com: Benefits portal, formulary lookup, PA status, EOB review
  • Availity: availity.com — for provider PA submissions under WV SB 267
  • West Virginia Insurance Commissioner: 1-888-879-9842 | wvinsurance.gov — for coverage disputes and insurance complaints
  • U.S. Department of Labor EBSA: 1-866-444-3272 — for ERISA self-funded plan appeals and disputes
  • West Virginia DHHR (Behavioral Health Services): 1-844-HELP4WV for state behavioral health resources (separate from weight loss, provided for reference)

Frequently Asked Questions

Does Cigna cover Zepbound for weight loss in West Virginia?

Zepbound (tirzepatide) typically remains on the Cigna/ESI commercial formulary at Tier 3–4 with prior authorization. Unlike CVS/Caremark (Aetna’s PBM), Express Scripts did not remove Zepbound from its commercial formulary. Coverage requires meeting PA criteria — typically BMI ≥ 30, or BMI ≥ 27 with a qualifying comorbidity — and your provider must submit a PA request via Availity under WV SB 267. Verify your specific plan’s current formulary at myCigna.com.

Does Cigna cover Wegovy in West Virginia?

Wegovy (semaglutide) may be covered under Cigna commercial plans through the ESI formulary at Tier 3–4, subject to prior authorization. PA criteria typically include BMI ≥ 30 or BMI ≥ 27 with a comorbidity, plus documentation of a prior structured weight management attempt. Coverage and cost-sharing depend on your specific plan design — confirm through myCigna.com or by calling 1-800-244-6224.

Do I need a referral to see a weight loss provider under my Cigna WV plan?

Referral requirements depend on your plan type. OAP (Open Access Plus) plans typically do not require a referral to see a weight loss medicine specialist. HMO plans typically require a referral from your PCP. LocalPlus/SureFit plans do not require a referral but restrict you to an in-network provider list. Check your plan documents or myCigna.com to confirm your plan’s specific referral rules.

Does phentermine require an electronic prescription in West Virginia?

Yes. Phentermine is a Schedule IV controlled substance. Under W. Va. Code § 60A-4-403a, West Virginia requires electronic prescribing for all controlled substances — including Schedule IV. Your provider must be EPCS-compliant to prescribe phentermine in West Virginia. GLP-1 medications (Wegovy, Zepbound, Saxenda) are non-controlled and do not have this requirement.

Does West Virginia’s mental health parity law require Cigna to cover weight loss medications?

No. W. Va. Code § 33-25-8r et seq. is West Virginia’s mental health and substance use disorder parity statute — it governs parity for mental health and SUD benefits, not weight loss. Weight loss medication coverage is governed by ACA essential health benefits rules (for Marketplace plans) and employer plan design (for employer-sponsored plans). ERISA self-funded plans are not bound by West Virginia state coverage mandates. Contact the WV Insurance Commissioner at 1-888-879-9842 if you believe a coverage denial was improper.

What should I do if Cigna denies my prior authorization for a weight loss medication?

If Cigna denies your PA request, you typically have the following options: (1) Request a peer-to-peer review — your prescribing provider speaks directly with Cigna’s medical reviewer to discuss clinical necessity. (2) File a first-level internal appeal within the timeframe stated on your denial letter (typically 30–60 days). (3) If the first appeal is denied, request an external independent review through the WV Insurance Commissioner’s office (1-888-879-9842). For ERISA self-funded plans, contact the U.S. Department of Labor EBSA at 1-866-444-3272. Document all communications and keep copies of your PA submission materials.


Disclaimer: This article is for informational and educational purposes only. It does not constitute medical advice, insurance advice, or a guarantee of coverage. Coverage for weight loss treatment varies significantly by Cigna plan type, employer group, and plan year. Always verify your specific benefits through myCigna.com or by calling Cigna member services at 1-800-244-6224 before scheduling treatment or filling a prescription. Klarity Health is not affiliated with Cigna or Express Scripts.

Get expert care from top-rated providers

Find the right provider for your needs — select your state to find expert care near you.

Related posts

logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402

Join our mailing list for exclusive healthcare updates and tips.

Stay connected to receive the latest about special offers and health tips. By subscribing, you agree to our Terms & Conditions and Privacy Policy.
logo
All professional services are provided by independent private practices via the Klarity technology platform. Klarity Health, Inc. does not provide medical services.
Phone:
(866) 391-3314

— Monday to Friday, 7:00 AM to 4:00 PM PST

Mailing Address:
1825 South Grant St, Suite 200, San Mateo, CA 94402
If you’re having an emergency or in emotional distress, here are some resources for immediate help: Emergency: Call 911. National Suicide Prevention Lifeline: call or text 988. Crisis Text Line: Text HOME to 741741.
HIPAA
© 2026 Klarity Health, Inc. All rights reserved.